175 related articles for article (PubMed ID: 36319566)
1. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.
Mohammadi Y; Ahmadvand S; Mirtalebi M; Ashraf MJ; Khademi B; Ghaderi A
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S133-S142. PubMed ID: 36319566
[TBL] [Abstract][Full Text] [Related]
2. Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs.
Ahmadvand S; Norouzi LA; Mohammadi Y; Safaei A; Khademi B; Motiee-Langroudi M; Ghaderi A
BMC Immunol; 2024 Jan; 25(1):7. PubMed ID: 38229027
[TBL] [Abstract][Full Text] [Related]
3. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
4. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
5. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
[TBL] [Abstract][Full Text] [Related]
7. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract][Full Text] [Related]
8. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
10. CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Paulsen EE; Kilvaer T; Khanehkenari MR; Maurseth RJ; Al-Saad S; Hald SM; Al-Shibli K; Andersen S; Richardsen E; Busund LT; Bremnes R; Donnem T
Neoplasia; 2015 Nov; 17(11):839-48. PubMed ID: 26678911
[TBL] [Abstract][Full Text] [Related]
11. High Density of Intratumor CD45RO
Zhou C; Li J; Wu Y; Diao P; Yang J; Cheng J
J Oral Maxillofac Surg; 2019 Mar; 77(3):536-545. PubMed ID: 30395824
[TBL] [Abstract][Full Text] [Related]
12. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.
Zhu Y; Li M; Bo C; Liu X; Zhang J; Li Z; Zhao F; Kong L; Yu J
Cancer Immunol Immunother; 2017 Mar; 66(3):343-354. PubMed ID: 27915370
[TBL] [Abstract][Full Text] [Related]
14. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Infiltrating CD45RO
Ito N; Yamasaki S; Shintani T; Matsui K; Obayashi F; Koizumi K; Tani R; Yanamoto S; Okamoto T
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190149
[TBL] [Abstract][Full Text] [Related]
17. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.
Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH
Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
Hu C; Tian S; Lin L; Zhang J; Ding H
Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis.
Wahbi HS; Manadili A
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
